Boston, MA 04\/08\/2013 (wallstreetpr) – Affymax (NASDAQ:AFFY) closed at $1.16 on Friday\u2019s stock market, a drop by 0.01% from its previous close of $1.17. The company is a small cap, with a potential of 46.46M in revenues as reported yesterday. The earnings per share were -1.52, with a profit margin of -65.57% when NASDAQ closed. Affymax couldn\u2019t gear up to its target share price of 2.02, and sold dirt cheap at only $1.25. The company has witnessed a significant fall in its stock prices recently, contributing to its falling revenue generation. The company also reported its fourth quarter and year end 2012 financial results, affirming why the shares are falling consistently. The current stock trend is not viewed positively by the investors, resulting in a further drop in share selling prices.<\/p>\n
Silvercorp Metals (NASDAQ:SVM) was trading at $3.37 when NASDAQ closed on Friday, a\u00a0 0.04% drop from its previous day closing share price. The market cap achieved was 597.73M, with only 0.18 earnings per share. The profit margin remained good despite of a fall in the share prices and floated around 24.75%. Investors were speculating a price of $7.42, but the shares could only attain $3.50. The closing share price yesterday was pretty close to its 52 week low of $3.35. Specializing in silver and other precious metals, Silvercorp provide the latest update about its class action and defamation case that was primarily considered the reason behind its dropping share price. Furthermore, it is among the top five toxic stocks that investors should sell in April.<\/p>\n
Dynavax Technologies Corporation (NASDAQ:DVAX) is a drug manufacturing company in the United States, which traded up by 1.27% on Friday\u2019s stock market. Its shares closed at a price of $2.39, which is higher than its previous close of $2.36. Simultaneously, Dynavax gained a market cap of 413.31M, with earnings per share of $-0.33. Despite of the growth, the profit margins floated low at -277.60%. Furthermore, the stocks failed to meet the investors\u2019 speculation of $4.17 price per share. Of late, the company announced its plan to hire for strategic global operations. According to market analysts, Dynavax is a lucrative buy.<\/p>\n","protected":false},"excerpt":{"rendered":"
Boston, MA 04\/08\/2013 (wallstreetpr) – Affymax (NASDAQ:AFFY) closed at $1.16 on Friday\u2019s stock market, a drop by 0.01% from its previous close of $1.17. The […]<\/p>\n","protected":false},"author":6,"featured_media":5992,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[263],"tags":[1985,1988,1693,991,1987,1986],"stock_ticker":[],"class_list":["post-5991","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-affymax-nasdaqaffy","tag-dynavax-technologies-corporation-nasdaqdvax","tag-nasdaqaffy","tag-nasdaqdvax","tag-nasdaqsvm","tag-silvercorp-metals-nasdaqsvm","entry"],"acf":[],"yoast_head":"\n